Are you ready for the new asthma guideline?
New BTS/NICE/SIGN Guideline on Asthma: diagnosis, monitoring and chronic asthma management 2024
Today (27th November) the National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) publish their long-awaited single guideline on asthma diagnosis, monitoring and management.
This update to the guideline is likely to represent a sea change in the management of asthma and will require significant change in primary care. To support you in preparing for and implementing changes in your practice, we have produced a range of resources including a first steps guide, signposting infographic and webinar.
Please access the resources below and share with your colleagues:
Summary guide: First steps to implement the guidance
This is a high-level summary of what the new BTS/NICE/SIGN Asthma: diagnosis monitoring and chronic asthma management guideline means for you as a primary healthcare professional and what steps you need to take to implement it effectively. This document is a distillation of the new guidance to provide distinct advice on the changes on the diagnosis and management to asthma.
📄 Get the guide.
Useful links infographic
We've gathered links to relevant primary care-based tools to help you to be prepared. This list is not intended to be comprehensive but provides a starting point for helping you to prepare for and implement change in your practice in line with the new guidance.
🔗 Download infographic.
Webinar: What the new guideline means for you
AstraZeneca has provided sponsorship towards this independent programme and has had no involvement in its creation or organisation.
Join our webinar on the 2nd December, 13:00-14:00 to explore the crucial changes to asthma care and what primary care will need to consider to be able to implement the changes in practice.
Due to popular demand, we have released more places on this webinar. If you are unable to join us for the live webinar, an on demand recording will be available 48 hours after broadcast.
🖥️ Register now.
You may also be interested in...
This is a high-level summary of what the new BTS/NICE/SIGN Asthma: diagnosis monitoring and chronic asthma management guideline means for you as a primary healthcare professional and what steps you need to take to implement it effectively.
AstraZeneca has provided sponsorship towards this independent Programme and has had no involvement in its creation or organisation
This webinar is part of the PCRS Maintenance and Reliever Therapy (MART) in asthma campaign which seeks to support understanding and implementation of MART in asthma, and, with that, best practice asthma care.